I’m thrilled to welcome Enancio. Together our technologies will offer optimal levels of speed and efficiency for the compression of genomic data, while complementing Illumina’s other informatics solutions.
MammaPrint + BluePrint together can help empower #breastcancer patients to make informed decisions by determining which patients may benefit from neoadjuvant therapy and those who are better served by going straight to surgery. Learn more here: https://t.co/qx68y0F0vR
We are thrilled by @illumina’s partnership with @BlueBeeGenomics and look forward to accelerating growth and helping #breastcancer patients by streamlining workflow and using the best in class cloud-computing provider to ensure accurate and timely testing. https://t.co/N5z46qioav
Together with @Illumina we will merge high power computing and advanced data science technologies to help propel genomics forward and deliver on its clinical promise.
Welcome to the Illumina family, @BlueBeeGenomics. Together we will provide the most scalable, efficient, and extensible genomic analysis solutions for both clinical and translational research use cases.
https://t.co/SIEv5HDInN
#LiquidBiopsy with confirmatory PET-CT used to diagnose 26 women with local, regional, or stage 1 cancers and begin treatment in early stages when it is most effective. https://t.co/4IxBYYuahW
Reserve your spot for next Tuesday’s webinar: The Scientific Informatics of Biology in Bio-pharma and Bio-materials.
The focus will be on foundational #informatics tools needed in biological drug and material discovery today.
https://t.co/9VbQzxU8Yy
#pharma#drugdiscovery
It's a good day here at TruGenomix. CEO & Co-Founder Charles Cathlin is featured in @Militarydotcom. Learn about his inspiring career & the work we're doing today: Read: "A 9/11 Responder & Veteran Has a Better Way to Diagnose #PTSD" https://t.co/umWW2GM4kd Thanks @blakestilwell
In a #GWAS study, variants in both the ABO blood group locus and a cluster of genes on human chromosome 3 are more common among #COVID19 patients with respiratory failure than in the general population.
https://t.co/seAaGqDHKs
#coronavirus#genomics#precisionmedicine
Scientists based in Italy studying the #exomes of patients with #COVID19 identified links between genetic and molecular markers and susceptibility to infection, as well as disease severity. https://t.co/h5wD6Rhrx0
Meet Siren, a US Air Force Fighter Pilot. This PTSD Awareness Month, we're proud to launch TruStories by TruGenomix: An Interview Series Shedding Light on PTSD as Told by Survivors. Here's Siren's Story: https://t.co/sK51CeX47W
#PTSD#PTSDAwareness#PTSDAwarenessMonth
Register now for #RNASeq applications and technology overview webinar by @lexogen in less than 1.5hr! Registrants will receive the recording to watch on demand. Join Dr. Lauren Sheehan of Lexogen, et al!
Register now for #RNASeq applications and technology overview webinar by @lexogen in less than 1.5hr! Registrants will receive the recording to watch on demand. Join Dr. Lauren Sheehan of Lexogen, et al!
June is #PTSDAwarenessMonth. At TruGenomix, our year-round mission is to save lives, reduce suffering & eradicate stigma from #PTSD through earlier & more effective diagnosis & treatment of PTSD. https://t.co/J5OpZwKJhl
#PTSDAwareness#MentalHealth#BehavioralHealth
As an @illumina Accelerator company led by African American founders, TruGenomix appreciates Illumina CEO, @fdesouza’s public acknowledgment of our nation’s struggles with racial inequalities. #BlackLivesMatter https://t.co/eqv03tXgcm
Choosing the right technology for your precision medicine trial is crucial as you consider cost and the wealth of information.
An evaluation of WGS, WES & panel sequencing with a focus on oncology can be found here:
https://t.co/26yzgFAcOj
#Genetics#Genomics#ClinicalTrials
Join for RNA NGS! One more day to register - for current users of @lexogen pipelines powered by BlueBee or those who are completely new to #RNAseq & #data analysis.
Tomorrow June 9 at 8 am PT | 11 pm ET | 5 pm CEST
Register: https://t.co/RPvLfEuIZy
#transcriptome#NGS#RNA